What pathogens activate the lectin pathway?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pathogens That Activate the Lectin Pathway of Complement

The lectin pathway of complement is primarily activated by mannose-binding lectin (MBL), ficolins, and collectins recognizing carbohydrate patterns on microbial surfaces including bacteria, viruses, fungi, and parasites. 1, 2

Key Activating Pathogens

Bacterial Pathogens

  • Staphylococcus aureus - Recognized through cell wall components 3
  • Staphylococcus epidermidis - Activates via glycerol teichoic acid and polysaccharide intercellular adhesion 3
  • Streptococcus species - Including S. equinus and S. viridans via glycosyl transferases 3
  • Enterococcus faecalis - Through aggregation substance (Agg) and endocarditis-associated antigen A 3
  • Listeria monocytogenes - Via alginate structures 3
  • Pseudomonas aeruginosa - Through hyphal wall proteins 3
  • Coxiella burnetii - Activates the lectin pathway during Q fever infection 3
  • Yersinia pestis - Plague-causing bacterium recognized by MBL 3

Viral Pathogens

  • Coronavirus - Including SARS-CoV, which binds to L-SIGN receptors and activates the lectin pathway 3
  • Encephalitis viruses - Including alphaviruses from the Togaviridae family 3

Fungal Pathogens

  • Candida albicans - Via mannose-containing structures on cell walls 3
  • Candida parapsilosis - Recognized through cell surface carbohydrates 3

Mechanism of Lectin Pathway Activation

  1. Recognition Phase:

    • Pattern recognition molecules (MBL, ficolins, collectin-11) bind to carbohydrate patterns on pathogen surfaces 2
    • Common targets include mannose, N-acetylglucosamine, and other sugar moieties 1
  2. Activation Phase:

    • Upon binding, MBL-associated serine proteases (MASPs) undergo conformational changes
    • MASP-1 activates MASP-2
    • MASP-2 cleaves complement components C4 and C2 2
    • Formation of C3 convertase (C4b2a) occurs
  3. Amplification and Effector Phase:

    • C3 convertase cleaves C3 into C3a and C3b
    • C3b opsonizes pathogens for phagocytosis
    • Formation of membrane attack complex leads to pathogen lysis 4

Clinical Significance

  • Sepsis and Septic Shock: Lectin pathway activation contributes to inflammatory response during sepsis 5
  • Recurrent Infections: Deficiencies in lectin pathway components increase susceptibility to infections 3
  • Rheumatic Heart Disease: Lectin pathway activation may contribute to pathogenesis following streptococcal infections 4
  • COVID-19: Lectin pathway may be involved in the inflammatory response to SARS-CoV-2 3

Pathogen Evasion Strategies

Many pathogens have evolved mechanisms to evade the lectin pathway:

  • Molecular Mimicry: Pathogens disguise their surface structures to avoid recognition
  • Proteolytic Degradation: Some pathogens produce proteases that degrade MBL and ficolins
  • Recruitment of Host Regulators: Pathogens may bind host complement regulatory proteins 6

Clinical Applications

  • Diagnostic Potential: Measuring lectin pathway components may help identify immunodeficiencies
  • Therapeutic Targets: Modulation of the lectin pathway could be beneficial in infections where complement overactivation contributes to pathology
  • Prophylaxis: In patients with complement deficiencies, antimicrobial prophylaxis may be indicated 3

Understanding which pathogens activate the lectin pathway has important implications for diagnosing immunodeficiencies and developing targeted therapies for infectious diseases.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Innate Immunity

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.